SCHEMBL2968360

SCHEMBL2968360

CCCc1ccc(-c2nnc(CCCCO)o2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.54
SPHK1 Q9NYA1 3/20 0.45
SPHK2 Q9NRA0 2/20 0.44
NOTUM Q6P988 1/20 0.43
NR1H4 Q96RI1 1/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALOX12 P18054 1/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
DDX3X O00571 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2968358 0.86 MAPT (0.54) MAPTSPHK1SPHK2NR1H4KDM4E
SCHEMBL95172 0.85 NOTUM (0.60) MAPTSPHK1SPHK2NOTUMNR1H4
SCHEMBL1313658 0.83 SPHK1 (0.53) MAPTSPHK1SPHK2NOTUMNR1H4
SCHEMBL13340753 0.79 MAPT (0.53) MAPTSPHK1SPHK2KDM4EALDH1A1
SCHEMBL95171 0.79 MAPT (0.55) MAPTNOTUMNR1H4KDM4EALDH1A1
SCHEMBL1313385 0.77 SPHK1 (0.50) MAPTSPHK1SPHK2NOTUMKDM4E
SCHEMBL96694 0.77 SPHK2 (0.56) SPHK1SPHK2NOTUM
SCHEMBL7524142 0.77 MAPT (0.52) MAPTSPHK1SPHK2NR1H4KDM4E
SCHEMBL7520338 0.77 MAPT (0.52) MAPTSPHK1SPHK2NR1H4KDM4E
SCHEMBL12419524 0.74 LPL (0.51) MAPTSPHK1SPHK2NOTUMNR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 MAPT 4773/4885SPHK1 531/4885SPHK2 471/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 MAPT 4773/4885SPHK1 531/4885SPHK2 471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.